May 31, 2023
Gavin Wood and Christian Eberle join Atlas Antibodies’ Board of Directors

We are delighted to announce Gavin Wood and Christian Eberle as additions to our Board of Directors, elected by the AGM as of May 31 2023.

Åsa Riisberg was re-elected as Chair of the Board and Mathias Uhlen, Lotta Ljungqvist and Louise Kores were re-elected as Board members.

Gavin Wood and Christian Eberle
Gavin Wood and Christian Eberle

May 01, 2023
Dr. Stefan Schmidt new CEO of evitria

Changes are afoot at Swiss company evitria: As of May, Dr. Stefan Schmidt will take over the helm of the company, which specializes in the production of recombinant antibodies for medicine and research.

January 30, 2023
Peter Ulvskjold steps in as interim CEO for the Atlas Antibodies Group

The Board of Atlas Antibodies and Nille Klaebel have together agreed that Nille will leave her position as the CEO of Atlas Antibodies Group. Peter Ulvskjold, currently CEO of the division Atlas Antibodies, will assume the role as interim CEO for the Group, as of February 1st.

December 11, 2022
Atlas Antibodies has new Chair of the Board Åsa Riisberg

Åsa Riisberg, professional board member and former partner of EQT AB, has been appointed new Chair of the Board of Patricia Industries' wholly owned subsidiary Atlas Antibodies, a leading fast-growing provider of innovative and high-quality antibodies and recombinant antibody expressions to researchers around the world. Åsa Riisberg will succeed Torben Jørgensen, who leaves the Board, effective January 1, 2023.

September 30, 2022
Peter Ulvskjold appointed as new Atlas Antibodies’ CEO

Atlas Antibodies is pleased to announce Peter Ulvskjold as the new CEO with effect from the 1st of October 2022.

Peter Ulvskjold joined Atlas Antibodies from his role as Chief Transformation Officer at ConvaTec.

August 17, 2022
Atlas Antibodies supports the development of a new technique

MolBoolean is expected to be a valuable tool for researchers studying protein activity in cells and tissue and, in the long term, be used in healthcare to improve diagnosis and choice of treatment for cancer. Atlas Antibodies recently overtook the patent for MolBoolean and is now preparing the method for the market.

July 18, 2022
Great time with neuroscientists at FENS 2022

What a great beginning of the summer for our company in Paris at #FENS2022, the largest European international gathering for neuroscientists.

May 22, 2022
Winner of the Atlas Antibodies’ travel grant of 500 euros to attend the FENS Forum 2022 in Paris

We are happy to announce that Chiara Musillo, a Ph.D. student from La Sapienza University of Rome, Italy, is the recipient of the Atlas Antibodies’ travel grant of 500 euros to attend the FENS Forum 2022 in Paris, 9-13 July.

April 28, 2022
Atlas Antibodies nearly tripled its size during 2021

The Swedish biotech company Atlas Antibodies lands its best annual results to date. Strategic acquisitions and a progressive business plan have paved the way for organic growth above 30 pct. and a nearly three-fold increase in revenue. Danish CEO Nille Klæbel is persistently on the lookout for more companies to add to the Atlas Antibodies family of protein-centric businesses.

February 23, 2022
Atlas Antibodies’ products enriches Biomol’s offer

Dr. Caroline Kampf, Chief Scientific Officer at Atlas Antibodies, gave an interview for our new distributor Biomol from Germany. She talked about the history of our company, the high specificity of our polyclonal antibodies, applications for the customers and much more…

December 21, 2021
1,200 New Triple A Polyclonals

We are happy to announce the release of 1,200 new Triple A Polyclonals™. Atlas Antibodies now offers over 22,000 highly validated primary antibodies for tissue and cell analysis.

December 03, 2021
New PrecisA Monoclonals for analysis of brain and neuroendocrine tumors

We continuously expand our portfolio of cancer research related products. Our latest set of mouse monoclonals focuses on markers for glioma and neuroendocrine tumors.

October 11, 2021
Atlas Antibodies & T-Cure Biosciences

T-Cure Biosciences, Inc. and Atlas Antibodies AB have entered a collaboration agreement for the development, manufacture, and supply of CT83 (KK-LC-1) monoclonal antibodies for diagnostic use.

August 20, 2021
Atlas Antibodies AB appoints Nille Klæbel as new CEO

Atlas Antibodies is pleased to announce Nille Klæbel as the new CEO with effect from 15 September 2021.

“We are delighted to welcome Nille as the new CEO of Atlas Antibodies” says Torben Jørgensen, chairman of the Board of Directors and continues: “With her strong background in marketing and sales and knowledge of the life sciences, pharma and healthcare industries, Nille is highly equipped to lead the next important steps in the development of Atlas Antibodies into a global life sciences company.”

August 03, 2021
Atlas Antibodies is awarded ISO 9001:2015 Certification for Quality Management System

Atlas Antibodies is pleased to announce it has received ISO 9001:2015 certification. ISO 9001 is the internationally recognized standard for a quality management system (QMS) and organizations adhere to the standard to organize and continually improve business processes and efficiency.

July 28, 2021
Atlas Antibodies acquires evitria

Press release

Stockholm / Zürich, July 28, 2021

February 15, 2021
Atlas Antibodies acquires HistoCyte Laboratories Ltd.

Press release

Stockholm / Newcastle upon Tyne, February 15, 2021

February 04, 2020
New monoclonals for cancer research

We are delighted to release 50 new PrecisA Monoclonals focusing on protein targets for cancer research, including markers for cancer processes and different tumor types.

January 28, 2020
Join our webinar on QPrEST standards

Register today for our free webinar "Quantitative Analysis of Plasma Proteins by Targeted Mass Spectrometry”, held on February 25, 2020. 

January 28, 2020
How to determine the validity of an antibody for use in Western Blot

Fundamental to the success of a Western blot procedure is the ability of the primary antibody to detect the protein of interest. But how to validate an antibody for Western blot? Read our latest blog post to find out.

January 13, 2020
Separating proteins with a similar size in WB

Proteins of the same length or similar size such as isoforms of the same protein, are difficult to separate using the Western blot application. With some adjustments you can however achieve great results. In today's blog post we share our best tips. 

December 19, 2019
Business hours during the holidays

We wish to extend a sincere thank you to all our customers and partners in 2019. It has been a pleasure to work with you and we look forward to 2020!

We also would like to take this opportunity to inform about our shipping and business hours during the holidays.  

December 05, 2019 | Washington DC
Join us at ASCB in Washington DC

The ASCB/EMBO meeting starts this weekend in Washington DC and we hope to see you there. 

We will be joined by scientists from the Human Protein Atlas, and we are all looking forward to giving you a demo of the Cell Atlas. Come by our booths #425 and #427. 

November 26, 2019
Interview with a scientist - the past, present and future of the Cell Atlas

In today's blog post, we interview Dr. Peter Thul, group leader at the Human Protein Atlas (HPA) project, Stockholm, Sweden. Dr. Thul is one of the scientists behind the Cell Atlas: a database that provides high-resolution insights into the expression and spatio-temporal distribution of proteins within human cells. We asked Peter 10 questions about the past, the present, and the future of the Cell Atlas.

November 20, 2019
Don't miss our Brain Atlas webinar today

The webinar "The Brain Atlas: A road map through the complex protein signature of the brain" is held today at 12 pm ET, hosted by AAAS/Science. 

Professor Mathias Uhlén and Dr. Evelina Sjöstedt from the Human Protein Altas will give you an introduction to the new Brain Atlas section of the Human Protein Atlas and to the research behind it. 

Register today at the AAAS/Science website

November 19, 2019
Highlights from SFN in Chicago

In today's blog post, we share our favorite highlights from the Annual Society for Neuroscience (SfN) meeting last month. The SfN meeting features the latest discoveries in brain research, from the basic mechanisms, to translational and clinical studies. This year, the conference celebrated its 50th anniversary in the “Windy City”, Chicago, IL, USA. Unsurprisingly, this convention attracted close to 30,000 delegates around the workings of the brain “the universe between your ears” unassuming, but possibly, the most complex structure of the universe.

Read our blog post to learn about the research we found most exciting at the meeting

November 04, 2019
Webinar Introducing the Brain Atlas

In collaboration with Science/AAAS, we're introducing the webinar "The Brain Atlas: A road map through the complex protein signature of the brain", to be held on November 20.  Register today to learn about the research behind the Brain Atlas from Human Protein Atlas scientists.

October 29, 2019
Interview with Dr. Mulder, director of the Brain Atlas

In today's blog post, we interview Dr. Jan Mulder, group leader of the Fluorescence Tissue Profiling facility at Karolinska Institutet, Sweden. Dr. Mulder is the director of the Brain Atlas, the latest addition to the Human Protein Atlas database. We asked Dr. Mulder 10 questions about the past, the present, and the future of the Brain Atlas.

October 16, 2019
Join us at SFN in Chicago

We hope to meet you at SFN in Chicago later this week!

Come by our booth and tell us about your research and let us know what we can offer to help. We will be joined by scientists from the Human Protein Atlas, and we are all looking forward to giving you a demo of the Brain Atlas, the latest addition to the Human Protein Atlas.

October 15, 2019
Mapping the human brain - a guide to the brain atlas

The Brain Atlas one of the latest additions to the Human Protein Atlas database, bringing human brain mapping to a new level.

September 17, 2019
How buffers and chemicals affect the success of your IHC experiment

Do you know how many buffers can affect you IHC staining? In our latest blog post, we offer 10 essential tips on how to choose and prepare buffers for IHC.

September 15, 2019
Press Release

Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins using Mass Spectrometry

STOCKHOLM, Sweden, September 15, 2019. Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS).

September 05, 2019 | Stockholm, Sweden
Human Protein Atlas launches the Brain Atlas, Blood Atlas and Metabolic Atlas

Today, the Human Protein Atlas released the 19th version of the database including three new atlases; the Brain Atlas, the Blood Atlas and the Metabolic Atlas.

July 22, 2019
An Overview of the Cell Atlas on the Human Protein Atlas

The human body is the results of trillion of cells communicating with each other. Early biologists described cells as simple membranous sacs containing fluid and a few floating particles. Today we know that cells are infinitely more complex than that. In our latest blog, you can learn about the Cell Atlas, part of the Human Protein Atlas, for insights into the spatio-temporal distribution of proteins within human cells. Discover how you can use the Cell Atlas in our research.

June 25, 2019
Multiplexing - how to stain multiple proteins in the same cell or tissue?

As a rule, the complex biology and spatial organization of tissues and solid tumors pose a scientific and diagnostic challenge that is not sufficiently well addressed by standard immunohistochemistry (IHC) procedures. How come this is the case? The answer is that single IHC staining provides data on only one marker at a time. So, how do you stain multiple proteins in the same cell or tissue? Learn more in our latest blog. 

June 18, 2019 | Atlanta
Meet us at ISSCR in Atlanta

Next week, we will be at the ISSCR 2019 Annual Meeting in Los Angeles, CA, USA. If you are planning to attend the meeting, make sure to visit our booth, #1027. We look forward to meeting you and to hear about your research! We're also happy to give you a demonstration on how to use the Human Protein Atlas and present our antibodies for stem cell research. 

June 11, 2019
3 steps to publish a paper using the Tissue Atlas - a case study

n our latest blog post, we share the story from when Human Protein Atlas scientists were contacted by another research team with a question and a problem. This lead to a collaboration and published paper on a potential drug target for diabetes type II. 

Read our case study and find out how the Human Protein Atlas was used in the study. 

May 28, 2019
Past, Present and Future Challenges of Multiplex IHC

Multiplex IHC is a powerful investigative tool which allows for the simultaneous visualization of multiple proteins on a single section by using a specific antibody for each protein of interest. In our latest blog series "Interview with a Scientist", we investigate the past, present and future challenges of multiplex IHC. 

May 14, 2019
Using Antibodies for Human Proteins in another Model Organism

Can you make use of an antibody that targets a human protein in another model organism? Under the right conditions, the answer is yes! There are a few things you need to consider before you start. Learn more in our new blog. 

April 23, 2019
New White Papers - Neural Stem Cell Markers and Mesenchymal Stem Cell Markers

Interested in stem cells? Whether you are working in the field are simply interested in learning about different types of stem cells, download and read our two new white papers. 

April 16, 2019
How to Succeed with Your IHC - Antigen Retrieval

Now you can read the second part of our multi-chapter guide to succeeding with your IHC. This time, the focus is on antigen retrieval.

The antigen retrieval step can be the key to succeeding with your IHC experiment. Sample fixation in IHC can lead to protein cross-linking, which masks antigens limiting the antigen-antibody binding. Antigen retrieval is the technique in which the masking of an epitope is reversed, and epitope-antibody binding is restored. Read our blog to learn all about antigen retrieval.

April 02, 2019
How to Succeed with Your IHC - Tissue Processing

Now you can read the first part of our multi-chapter guide to succeeding with your IHC.

In part I, we'll share our best advice on tissue processing and handling. The most common cause of poor immunostaining is not the technique itself but the potential influence on the antigenic sites during tissue preparation. The quality of the staining, resulting from the antibody-antigen binding, is to a degree affected by alterations during tissue handling and tissue processing. Some proteins are most susceptible to changes in fixation than others. Read our blog to learn how to make sure you get the most out of your tissue samples.

March 29, 2019
Meet us at AACR in Atlanta

Atlas Antibodies will be exhibiting at the AACR meeting in Atlanta, March 29 - April 3. Visit us in booth 3245 and get a demo of the Human Protein Atlas and the Pathology Altas.  We're looking forward to hearing about your research and discuss what we can offer for your cancer research needs. 

March 19, 2019
New Blog - Artifacts in IHC: The Usual Suspects

An IHC experiment is a combination of three major elements: the sample, the application that is used and the experimental protocol. An excellent IHC staining is achieved when all the required elements, qualities and characteristics are matched perfectly. What if your experiment does not turn out as you planned? If you are looking for suspects to blame for artifacts in your IHC experiment, the three usual suspects are the sample, the antibodies and the protocol.  

In our latest blog post, we explain how you can identify which of the suspects are causing problems in your staining and what to do about it. 

March 13, 2019
Labroots Online Neuroscience Conference March 13-14

Join us at Neuroscience 2019, an online conference hosted by Labroots. The conference starts today at 2 pm CET/ 6 am PT. Listen to great talks, check out posters and find us and other companies in the exhibition hall. Registration is free and no travel is needed. We hope to see you there! You can also access the conference content on demand after the live dates. 

March 08, 2019
The Pathology Atlas - A Discovery Journey in Cancer Research

Cancer is a collection of related diseases in which some of the body’s cells begin to divide without stopping and spread into surrounding tissues. There are at least 200 forms of cancer, and many more subtypes. Different cancers can require different treatments, like chemotherapy, radiation therapy, or immunotherapy. But how do cancers differ in types? How is the same cancer different among individuals? 

Our latest blog post explores the Pathology Atlas,  an open-access database part of the Human Protein Atlas with the scope of identifying the role of genes, RNA, proteins, and metabolites in the complex human cancerous tissues and organs.

Read the blog to discover how the Pathology Atlas allow pathologists to improve testing methods to predict and find new treatments to fight cancer. 

March 08, 2019
Going to the Alpbach Affinity Proteomics Workshop?

At Atlas Antibodies we are proud to sponsor the 9th Alpbach Workshop on Affinity Proteomics to be held on March 11-13 in Austria. 

The Alpbach workshop is regarded as one of the best meetings on antibodies and other protein-binding molecules and their role in defining the proteome. We look forward to presenting our efforts into antibody validation at the meeting and how Enhanced Validation ensures reliable research results.

February 19, 2019
New Antibody Targeting Microglial Marker TMEM119

Today we are delighted to introduce a new PrecisA Monoclonal targeting TMEM119. 

TMEM119 (Transmembrane Protein 119) is a useful marker for studying microglia. An advantage over other microglial markers is that TMEM119 is specific for microglia, and not expressed by macrophages.

Our mouse monoclonal Anti-TMEM119 Antibody (AMAb91528) is validated for IHC, WB and ICC-IF. The target specificity of the Anti-TMEM119 antibody has been confirmed using orthogonal enhanced validation, by analyzing the relative expression of the target protein in different samples using both IHC and transcriptomics.

February 18, 2019
IHC Controls: Primary Antibody Controls

How much time do you spend making a decision for the right control for your primary antibody? And how do you know if you make the right choice? 

Primary antibody controls are used to verify the specificity of the primary antibody binding to the antigen of interest. Also, controls for the primary antibody are applied to confirm the correctness of the preanalytical IHC phase related to sample preparation, such as fixation,  post fixation, storage, and processing. It is important to include these controls for each new antibody, protocol, and application that you test. 

Read our new blog post to learn how to control your IHC by choosing the right primary antibody  controls. Don’t forget to subscribe to the blog to never miss a new post.

February 04, 2019
Do You Have Your IHC Controls Under Control? New Atlas Antibodies Blog

In science, experimental controls eliminate alternative explanations of experimental results. In IHC, controls are necessary for the validation of staining results.

But how do you select the proper controls? The task to select and apply the correct controls is not easy. Selection of appropriate controls is not purely a technical issue. It requires in-depth knowledge of how the test will be used.

In our new blog post, we help you on your way to figuring out which controls to use in your experiment, 

January 22, 2019
Learn How To Use The Human Protein Atlas: Part I - Three Ways To Navigate The Tissue Atlas

A fundamental part of studying and understanding human biology is the study of tissue-specific gene expression and protein levels. Tissue-specific gene expression can result in the presence or absence of a certain protein, leading to the profound functional variation of biological processes among tissues. This means, the knowledge of protein profiles in a given tissue is critical to understanding the unique characteristics of the various cell types and their functions in the human body.

The expression of all protein-coding genes in all major tissues and organs in the human body can be explored in the Human Protein Atlas, an interactive database, which includes a catalog of proteins expressed in a tissue-oriented manner.

Our new blog post is here to help you on your way to discovering the potential of the Human Protein Atlas. 

January 08, 2019
New Blog Post - How Do I Know If I Can Trust My Antibody?

Choosing a highly validated antibody with premium quality is an essential starting point to drive your results in the desired direction. It is important to choose an antibody that can be trusted, that is reproducible, and that work in specific tissue-application combination you plan to use. Even a good antibody can fail if used in the wrong context. So, if you do have a choice, look for an antibody you can trust and increase your chances of success. But how can you know if you can trust an antibody? Read our new blog post to find out. 

January 03, 2019
Let's Meet in 2019 - Upcoming Conferences

We are looking forward to seeing you in 2019!

Our conference schedule is updated with new meetings and conferences, and we hope to have the opportunity to meet you during the year. Atlas Antibodies will exhibit at the AACR, ISSCR, HUPO, SFN meetings and several more international conferences during 2019. If  you are planning to attend any of these events we hope to see you in our booth.